Skip to Main Content

Author Details

Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
2001
157
64
PMIDPaper TitleJournal TitlePublished Year
38039923Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma.Neoplasia2024
36760203Identification of androgen response-related lncRNAs in prostate cancer.Prostate2023
37717923Nested and Large Nested Subtypes of Urothelial Carcinoma of the Upper Urinary Tract: A Multi-institutional Study.Mod Pathol2023
37483698Microbiome diversity in African American, European American, and Egyptian colorectal cancer patients.Heliyon2023
37704602Global impact of somatic structural variation on the cancer proteome.Nat Commun2023
37947608Increased Gene Expression of <i>C1orf74</i> Is Associated with Poor Prognosis in Cervical Cancer.Cells2023
37990267The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer.J Ovarian Res2023
37607007A hybrid breast cancer/mesenchymal stem cell population enhances chemoresistance and metastasis.JCI Insight2023
37873389Targeted inhibition of BET proteins in HPV-16 associated head and neck squamous cell carcinoma reveals heterogeneous transcription response.bioRxiv2023
37761830Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Triple-Negative Breast Cancers.Genes (Basel)2023
36951721Systemic Anti-Inflammatory Therapy Aided by Curcumin-Laden Double-Headed Nanoparticles Combined with Injectable Long-Acting Insulin in a Rodent Model of Diabetes Eye Disease.ACS Nano2023
37141409Using cancer proteomics data to identify gene candidates for therapeutic targeting.Oncotarget2023
37067340BZW2 Inhibition Reduces Colorectal Cancer Growth and Metastasis.Mol Cancer Res2023
34780648MS4A3 promotes differentiation in chronic myeloid leukemia by enhancing common β-chain cytokine receptor endocytosis.Blood2022
35852858ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors.JCI Insight2022
35626050Distinct Gene Expression Profiles of Matched Primary and Metastatic Triple-Negative Breast Cancers.Cancers (Basel)2022
35562349Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways.Nat Commun2022
35450897Meta-analysis of the robustness of COVID-19 diagnostic kit performance during the early pandemic.BMJ Open2022
36430867Developing 3D Organoid Raft Cultures from Patient-Derived Xenografts as Rapid Models to Screen Efficacy of Experimental Therapeutics.Int J Mol Sci2022
35948570Author Correction: Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways.Nat Commun2022
35194944DCZ0415, a small-molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4/STAT3 axis and the Wnt/β-catenin pathway in colorectal cancer.Mol Oncol2022
34864569Global molecular alterations involving recurrence or progression of pediatric brain tumors.Neoplasia2022
35078134UALCAN: An update to the integrated cancer data analysis platform.Neoplasia2022
33247371Subcellular localization of EZH2 phosphorylated at T367 stratifies metaplastic breast carcinoma subtypes.Breast Cancer2021
33627787Mass-spectrometry-based proteomic correlates of grade and stage reveal pathways and kinases associated with aggressive human cancers.Oncogene2021
33839593Comparative analysis of triple-negative breast cancer transcriptomics of Kenyan, African American and Caucasian Women.Transl Oncol2021
33501458Meta-Analysis of Robustness of COVID-19 Diagnostic Kits During Early Pandemic.medRxiv2021
34609963The TGF-β/HDAC7 axis suppresses TCA cycle metabolism in renal cancer.JCI Insight2021
34719204Expression of MHC class I polypeptide-related sequence A (MICA) in colorectal cancer.Front Biosci (Landmark Ed)2021
34538338Corrigendum to 'Targeting P4HA1 with a Small Molecule Inhibitor in a Colorectal Cancer PDX Model' [Translational Oncology 13 (2020) 100754].Transl Oncol2021
34075396NAB2-STAT6 Gene Fusions to Evaluate Primary/Metastasis of Hemangiopericytoma/Solitary Fibrous Tumors.Am J Clin Pathol2021
34049151Collagen modifying enzyme P4HA1 is overexpressed and plays a role in lung adenocarcinoma.Transl Oncol2021
32251515PRDM16 suppresses HIF-targeted gene expression in kidney cancer.J Exp Med2020
3190107814-3-3 proteins protect AMPK-phosphorylated ten-eleven translocation-2 (TET2) from PP2A-mediated dephosphorylation.J Biol Chem2020
31982456PGC1α suppresses kidney cancer progression by inhibiting collagen-induced SNAIL expression.Matrix Biol2020
31733288Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities.Cancer Lett2020
33037736TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status.Mol Oncol2020
32978169EZH2-Targeted Therapies in Cancer: Hype or a Reality.Cancer Res2020
32602122MicroRNA-mediated inflammation and coagulation effects in rats exposed to an inhaled analog of sulfur mustard.Ann N Y Acad Sci2020
32218208PAICS, a Purine Nucleotide Metabolic Enzyme, is Involved in Tumor Growth and the Metastasis of Colorectal Cancer.Cancers (Basel)2020
32231273Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression.Oncogene2020
32200644Fermentable fibers induce rapid macro- and micronutrient depletion in Toll-like receptor 5-deficient mice.Am J Physiol Gastrointest Liver Physiol2020
32559205Fermentable fiber-induced hepatocellular carcinoma in mice recapitulates gene signatures found in human liver cancer.PLoS One2020
32199274Targeting P4HA1 with a Small Molecule Inhibitor in a Colorectal Cancer PDX Model.Transl Oncol2020
32422575PAICS, a De Novo Purine Biosynthetic Enzyme, Is Overexpressed in Pancreatic Cancer and Is Involved in Its Progression.Transl Oncol2020
30602056Large-scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival.Cancer2019
31831737Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers.Nat Commun2019
30131446Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis.Mol Cancer Res2019
30089854Genome-wide DNA methylation encodes cardiac transcriptional reprogramming in human ischemic heart failure.Lab Invest2019
31376196Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancer.Prostate2019
  • 1 - 50 of 157

Recommended Authors

The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 12
Oncology R&D
Career Start Year 2013
Number of shared co-authors 21
the Second Hospital, Cheeloo College of Medicine, Shandong University
Career Start Year 2011
Number of shared co-authors 5
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 4
University of British Columbia
Career Start Year 2008
Number of shared co-authors 8
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 9
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 3
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 19
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 12
University of British Columbia
Career Start Year 2004
Number of shared co-authors 8
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 2
University of Cambridge
Career Start Year 2003
Number of shared co-authors 0
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 4
University of British Columbia
Career Start Year 2002
Number of shared co-authors 15
Meyer Cancer Center
Career Start Year 2001
Number of shared co-authors 25
University of British Columbia
Career Start Year 2000
Number of shared co-authors 25
VTT Technical Research Centre of Finland Ltd
Career Start Year 1999
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 8
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 2
Queen's University Belfast
Career Start Year 1997
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 2
RIKEN Center for Integrative Medical Sciences
Career Start Year 1994
Number of shared co-authors 2
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 3
The Institute of Cancer Research
Career Start Year 1990
Number of shared co-authors 27
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 6
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 6
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 1
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 32
University of California los angeles
Career Start Year 1970
Number of shared co-authors 23

Collaborators

University of Michigan Medical School.
Co-authored papers 79
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 32
University of Bern
Co-authored papers 26
Michigan Center for Translational Pathology.
Co-authored papers 25
Michigan Center for Translational Pathology.
Co-authored papers 22
Vattikuti Urology Institute
Co-authored papers 22
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 16
Co-authored papers 15
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 14
Co-authored papers 12
UT Southwestern Medical Center
Co-authored papers 11
Co-authored papers 10
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 9
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 9
Co-authored papers 8
Co-authored papers 8
University of Trento
Co-authored papers 6
Washington University in St Louis
Co-authored papers 6
University of Michigan ann arbor
Co-authored papers 5
Emory University
Co-authored papers 5
and School of Public Health, University of Michigan ann arbor
Co-authored papers 5
UCSF Medical Center-Mount Zion
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
University of California
Co-authored papers 4
Co-authored papers 4
University of Michigan ann arbor
Co-authored papers 4
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2